Proposed legislation has the potential to revitalize the global marketplace for novel antibiotics, bringing urgently needed medicines for drug-resistant infections to patients.
Site Search
The patient-centered outcomes research (PCOR) training manual provides discrete steps, tools, and resources that CF Center research teams can take to integrate and maintain patient/caregiver-partners in CF research.
Study reaffirms the Foundation’s commitment to advance solutions to the growing challenge of antibiotic resistance
Collaborative effort identifies 40 cases of COVID-19 across eight countries; outcomes for this high-risk population were reported in the Journal of Cystic Fibrosis
Investment will support discovery research of a novel Gene CodingTM approach that could benefit all people with CF regardless of their mutation
This medicine represents the single greatest therapeutic advancement in the history of CF, offering a treatment for the underlying cause of the disease that could eventually benefit more than 90 percent of people with CF.
Today, the Cystic Fibrosis Foundation awarded $2.76 million for 11 laboratory studies that will advance our understanding of the underlying factors that impact COVID-19 outcomes in people with cystic fibrosis. Ultimately, insights gained from this body of research may be used to improve future treatments.
The Cystic Fibrosis Foundation has joined 11 other patient groups in filing an amicus brief to challenge the short-term, limited-duration health insurance rule, which threatens access to adequate, affordable coverage for people with cystic fibrosis.
Observational study supported by the CF Foundation will monitor real-world experience with Trikafta
Equilibrar la vida escolar y social con la atención diaria para tu fibrosis quística puede ser algo abrumador, especialmente cuando sumas a la lista cómo manejar la alimentación. Sin embargo, cuando sabes de qué manera los alimentos, enzimas y suplementos pueden ayudarte a sentirte más enérgico y fuerte, equilibrar la vida con FQ puede ser más sencillo.